VectorBuilder Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • VectorBuilder's estimated annual revenue is currently $13.8M per year.(i)
  • VectorBuilder's estimated revenue per employee is $155,000

Employee Data

  • VectorBuilder has 89 Employees.(i)
  • VectorBuilder grew their employee count by 16% last year.

VectorBuilder's People

NameTitleEmail/Phone
1
Director Product DevelopmentReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
Managing Director, VectorBuilder Japan, Inc.Reveal Email/Phone
5
Territory ManagerReveal Email/Phone
6
Office ManagerReveal Email/Phone
7
Territory ManagerReveal Email/Phone
8
Scientific Product ManagerReveal Email/Phone
9
US MidWest-Atlantic Sr. Territory ManagerReveal Email/Phone
10
Technical Sales SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M18-14%N/AN/A
#2
$0.8M50%N/AN/A
#3
$2M130%N/AN/A
#4
$707.3M285214%$1.1BN/A
#5
$1.7M110%N/AN/A
#6
$32.6M2106%N/AN/A
#7
$2.6M176%N/AN/A
#8
$1.1M7-30%N/AN/A
#9
$1.4M9-10%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is VectorBuilder?

VectorBuilder is a revolutionary online platform for vector cloning. Researchers can use VectorBuilder's highly intuitive online tool to design their desired vectors, and order custom cloning services for these vectors along with related services such as virus packaging. Cost and turnaround time are a fraction of DIY.

keywords:N/A

N/A

Total Funding

89

Number of Employees

$13.8M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

VectorBuilder News

2022-04-17 - Week In Review: VectorBuilder Plans $500 Million Gene Therapy Delivery CDMO In Guangzhou

VectorBuilder says it offers gene therapy delivery services so biopharmas can focus on their candidates instead of developing their own vectors.

2022-04-13 - VectorBuilder to spend $500M to construct gene therapy ...

Chicago-based VectorBuilder will drop $500 million over the next four years in a two-phase project to build a new gene therapy manufacturing facility and...

2022-04-13 - VectorBuilder to Expand with $500 Million Gene Delivery ...

VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M89-36%N/A
#2
$18.7M891%N/A
#3
$20.2M89-1%N/A
#4
$28.9M89-29%$82.4M
#5
$13.4M8946%N/A